Calliditas Therapeutics AB (publ) (CALT) Short Interest Ratio & Short Volume $40.00 0.00 (0.00%) (As of 12/17/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Calliditas Therapeutics AB (publ) Short Interest DataCalliditas Therapeutics AB (publ) (CALT) has a short interest of 3,500 shares. This marks a -60.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 10,339 shares to cover all short positions.Current Short Interest3,500 sharesPrevious Short Interest8,900 sharesChange Vs. Previous Month-60.67%Dollar Volume Sold Short$140,420.00Short Interest Ratio0.4 Days to CoverLast Record DateAugust 31, 2024Outstanding Shares29,790,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume0 sharesAverage Trading Volume10,339 sharesToday's Volume Vs. Average0% Short Selling Calliditas Therapeutics AB (publ)? Sign up to receive the latest short interest report for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCALT Short Interest Over TimeCALT Days to Cover Over TimeCALT Percentage of Float Shorted Over Time Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Calliditas Therapeutics AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/20243,500 shares $140,420.00 -60.7%N/A0.4 $40.12 8/15/20248,900 shares $346,744.00 +39.1%N/A0.6 $38.96 7/31/20246,400 shares $246,080.00 -23.8%N/A0.5 $38.45 7/15/20248,400 shares $325,248.00 -9.7%N/A0.6 $38.72 6/30/20249,300 shares $362,607.00 +13.4%N/A0.7 $38.99 6/15/20248,200 shares $317,914.00 No ChangeN/A0.6 $38.77 Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 5/31/20248,200 shares $327,918.00 -16.3%N/A0.7 $39.99 5/15/20249,800 shares $216,940.64 +12.6%N/A1.8 $22.14 4/30/20248,700 shares $168,867.00 +22.5%N/A1.4 $19.41 4/15/20247,100 shares $134,545.00 +121.9%N/A1 $18.95 3/31/20243,200 shares $67,232.00 -56.2%N/A0.4 $21.01 3/15/20247,300 shares $163,958.00 +15.9%N/A0.5 $22.46 2/29/20246,300 shares $134,312.85 +37.0%N/A0.4 $21.32 2/15/20244,600 shares $94,668.00 -20.7%N/A0.3 $20.58 1/31/20245,800 shares $132,588.00 No ChangeN/A0.4 $22.86 1/15/20245,800 shares $145,000.00 -43.1%N/A0.4 $25.00 12/31/202310,200 shares $262,588.80 +20.0%N/A0.6 $25.74 12/15/20238,500 shares $187,765.00 -29.2%N/A0.6 $22.09 11/30/202312,000 shares $208,200.00 +26.3%N/A1.1 $17.35 11/15/20239,500 shares $161,215.00 +93.9%N/A0.9 $16.97 10/31/20234,900 shares $79,870.00 +63.3%N/A0.5 $16.30 10/15/20233,000 shares $52,050.00 -21.1%N/A0.3 $17.35 9/30/20233,800 shares $69,388.00 +40.7%N/A0.4 $18.26 9/15/20232,700 shares $43,104.42 -34.2%N/A0.3 $15.96 8/31/20234,100 shares $72,652.00 -48.1%N/A0.6 $17.72 8/15/20237,900 shares $152,707.00 +315.8%N/A1.1 $19.33 7/31/20231,900 shares $37,050.00 -24.0%N/A0.3 $19.50 7/15/20232,500 shares $40,125.00 +4.2%N/A0.4 $16.05 6/30/20232,400 shares $37,680.00 -51.0%N/A0.4 $15.70 6/15/20234,900 shares $89,363.75 -41.7%N/A0.8 $18.24 5/31/20238,400 shares $143,304.00 +47.4%N/A0.8 $17.06 5/15/20235,700 shares $145,350.00 +128.0%N/A0.5 $25.50 4/30/20232,500 shares $58,350.00 -77.3%N/A0.2 $23.34 4/15/202311,000 shares $272,250.00 -16.0%N/A0.8 $24.75 3/31/202313,100 shares $314,007.00 -42.3%N/A0.9 $23.97 3/15/202322,700 shares $572,948.00 +58.7%N/A1.6 $25.24 2/28/202314,300 shares $264,693.00 +346.9%N/A1.4 $18.51 2/15/20233,200 shares $57,472.00 +10.3%N/A0.3 $17.96 1/31/20232,900 shares $55,680.00 -52.5%N/A0.3 $19.20 1/15/20236,100 shares $120,780.00 -38.4%N/A0.6 $19.80Genesis leading the smart algo revolution? (Ad)I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!You’ll want to see what I’ve put on this page right here 12/30/20229,900 shares $168,300.00 +67.8%N/A0.9 $17.00 12/15/20225,900 shares $115,616.40 -38.5%N/A0.5 $19.60 11/30/20229,600 shares $174,432.00 +37.1%N/A0.8 $18.17 11/15/20227,000 shares $115,500.00 +25.0%N/A0.7 $16.50 10/31/20225,600 shares $83,440.00 +60.0%N/A0.6 $14.90 10/15/20223,500 shares $54,600.00 -59.3%N/A0.4 $15.60 9/30/20228,600 shares $130,428.46 +230.8%N/A1.4 $15.17 9/15/20222,600 shares $41,106.00 -27.8%N/A0.5 $15.81 8/31/20223,600 shares $59,400.00 -49.3%N/A0.8 $16.50 8/15/20227,100 shares $153,005.00 +4.4%N/A1.4 $21.55 7/31/20226,800 shares $126,820.00 -9.3%N/A1 $18.65 7/15/20227,500 shares $135,900.00 -22.7%N/A1.1 $18.12 6/30/20229,700 shares $172,175.00 -29.2%N/A1.3 $17.75 6/15/202213,700 shares $238,838.95 -19.9%N/A1.7 $17.43 5/31/202217,100 shares $305,235.00 -59.6%N/A1.8 $17.85 5/15/202242,300 shares $599,391.00 -34.0%N/A3.6 $14.17 4/30/202264,100 shares $942,911.00 -6.6%N/A5.7 $14.71 4/15/202268,600 shares $1.26 million -6.7%N/A4.1 $18.31 3/31/202273,500 shares $1.41 million -3.4%N/A3.4 $19.14 3/15/202276,100 shares $1.27 million +4.3%N/A2.1 $16.74 2/28/202273,000 shares $1.44 million +22.1%N/A0.4 $19.75 2/15/202259,800 shares $1.31 million -10.3%N/A0.3 $21.85 1/31/202266,700 shares $1.41 million -25.0%N/A0.4 $21.21 1/15/202288,900 shares $2.06 million +51.2%N/A0.5 $23.17 12/31/202158,800 shares $1.46 million -41.7%N/A0.3 $24.76 12/15/2021100,800 shares $1.88 million +94.2%N/A0.6 $18.64 11/30/202151,900 shares $954,441.00 +25.7%N/A1.4 $18.39 11/15/202141,300 shares $707,882.00 -29.3%N/A1.1 $17.14 10/29/202158,400 shares $953,088.00 +11.9%N/A1.4 $16.32 10/15/202152,200 shares $1.16 million +26.1%N/A1.6 $22.18 9/30/202141,400 shares $895,068.00 -56.0%N/A1.3 $21.62 9/15/202194,000 shares $2.13 million +67.0%N/A3 $22.71 8/31/202156,300 shares $1.59 million +50.1%N/A2.3 $28.18 8/13/202137,500 shares $1.13 million -18.7%N/A2 $30.15 7/30/202146,100 shares $1.34 million -3.0%0.2%3.5 $29.05 7/15/202147,500 shares $1.39 million +5.1%0.2%1.8 $29.20 6/30/202145,200 shares $1.33 million -12.2%0.2%1.4 $29.45 6/15/202151,500 shares $1.56 million -8.5%0.2%1.4 $30.39 5/28/202156,300 shares $1.67 million -0.5%0.2%1.5 $29.60 5/14/202156,600 shares $1.53 million +55.9%0.2%1.5 $27.12 4/30/202136,300 shares $1.08 million +58.5%0.2%0.9 $29.64 4/15/202122,900 shares $617,155.00 No Change0.1%0.6 $26.95 3/31/202122,900 shares $628,834.00 -4.6%0.1%0.7 $27.46 3/15/202124,000 shares $718,560.00 +211.7%0.1%1 $29.94 2/26/20217,700 shares $222,068.00 +102.6%0.0%0.3 $28.84 2/12/20213,800 shares $121,828.00 -24.0%0.0%0.2 $32.06 1/29/20215,000 shares $140,700.00 +11.1%0.0%0.1 $28.14 1/15/20214,500 shares $140,085.00 No Change0.0%0.1 $31.13 CALT Short Interest - Frequently Asked Questions What is Calliditas Therapeutics AB (publ)'s current short interest? Short interest is the volume of Calliditas Therapeutics AB (publ) shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 3,500 shares of CALT short. Learn More on Calliditas Therapeutics AB (publ)'s current short interest. Is Calliditas Therapeutics AB (publ)'s short interest increasing or decreasing? Calliditas Therapeutics AB (publ) saw a decrease in short interest in August. As of August 31st, there was short interest totaling 3,500 shares, a decrease of 60.7% from the previous total of 8,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Calliditas Therapeutics AB (publ)'s short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Calliditas Therapeutics AB (publ): ADMA Biologics, Inc. (5.46%), Ultragenyx Pharmaceutical Inc. (3.66%), Apellis Pharmaceuticals, Inc. (17.53%), Arcellx, Inc. (12.85%), Biohaven Ltd. (7.75%), Avidity Biosciences, Inc. (12.52%), Immunovant, Inc. (20.39%), Scholar Rock Holding Co. (15.76%), Organon & Co. (5.32%), PTC Therapeutics, Inc. (5.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks. What does it mean to sell short Calliditas Therapeutics AB (publ) stock? Short selling CALT is an investing strategy that aims to generate trading profit from Calliditas Therapeutics AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calliditas Therapeutics AB (publ)? A short squeeze for Calliditas Therapeutics AB (publ) occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CALT, which in turn drives the price of the stock up even further. How often is Calliditas Therapeutics AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CALT, twice per month. The most recent reporting period available is August, 31 2024. More Short Interest Resources from MarketBeat Related Companies ADMA Short Squeeze RARE Short Squeeze APLS Short Squeeze ACLX Short Squeeze BHVN Short Squeeze RNA Short Squeeze IMVT Short Squeeze SRRK Short Squeeze OGN Short Squeeze PTCT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CALT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CALT Stock Alerts